1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow BRII-835: new trials by email Literature Review of BRII-835 trials Research Report on BRII-835
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients PEG-IFNα, BRII-835 - Chronic Hepatitis B Virus Infection | Phase 2 | Completed | Brii Biosciences Limited | 86 | 2023-08-22 | 2026-10-20 |
Australia (1) · China (1) · Singapore (1) · South Korea (1) · Thailand (1)